摘要
Introduction: Although the indications for antiviral therapy for patients with chronic hepatitis B have been gradually expanded in different guidelines, antiviral treatment efficacy remains unclear among HBeAg-seropositive patients with alanine aminotransferase (ALT) < 2 upper limits of normal (ULN). This study aimed to evaluate the efficacy of antiviral therapy for these patients.Methods: In total, 102 treatment-naive patients who were HBeAg seropositive with ALT < 2 ULN and had received nucleotide analogs were included, and their clinical data were retrospectively analyzed.Results: After 96-week treatment, 84.3% (n = 86), 26.5% (n = 27) and 20.6% (n = 21) patients achieved virological response, HBeAg seroclearance and HBeAg seroconversion, respectively. Logistic regression analysis revealed that baseline AST (odds ratio [OR] = 1.069, 95% confidence interval [CI] 1.014-1.127, p = 0.014), serum HBV DNA (OR = 0.540, 95% CI 0.309-0.946, p = 0.031) and quantitative HBsAg levels (OR = 0.147, 95% CI 0.036-0.597, p = 0.007) were independent factors for virological response. At baseline, HBsAg < 4.63 log10 IU/ml was identified as a strong predictor for the 96-week virological response, with a concordance rate of 0.902. Moreover, the levels of liver stiffness values (8.30 +/- 3.86 vs. 6.17 +/- 1.91, p < 0.001) at week 96 had significantly declined compared to baseline.Conclusion: Nucleotide analog treatment effectively suppressed HBV DNA in patients with HBeAg-seropositive chronic hepatitis B with ALT < 2 9 ULN and greatly improved liver fibrosis. The study also found that HBsAg < 4.63 log10 IU/ml was a strong predictor of the virological response.
学科与关键词
- Effectiveness of antiviral treatment in HBeAg-negative chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase: a retrospective studyWei, Sufang; Hu, Meixin; Chen, Hongjie; Xie, Qiuli; Wang, Peng; Li, Hong; Peng, Jie*BMC GASTROENTEROLOGY, 2022, 22(1): 387.被引 1
- The Efficacy of Antiviral Treatment for Chronic Hepatitis B Patients with Normal ALT Levels: A Systematic Review and Meta-analysisQian, Zhe; Hu, Meixin; Wu, Houji; Chen, Hongjie; Liao, Guichan; Kang, Zixin; Lin, Xiaoli; Peng, Jie*Hepatitis Monthly, 2022, 22(1): e129836.
- Early hepatitis B viral DNA clearance predicts treatment response at week 96Fu Xiao Yu; Tan De Ming; Liu Cui Mei; Gu Bin; Hu Li Hua; Peng Zhong Tian; Chen Bin; Xie Yuan Lin; Gong Huan Yu; Hu Xiao Xuan; Yao Lian Hui; Xu Xiao Ping; Fu Zheng Yuan; He Lang Qiu; Li Si Hai; Long Yun Zhu; Li De Hui; Gu Ji Long; Peng Shi Fang*World Journal of Gastroenterology, 2017, 23(16): 2978-2986.
